Literature DB >> 12692521

Systemic capillary leak syndrome after granulocyte colony-stimulating factor (G-CSF).

Ian Rechner1, Finella Brito-Babapulle, Jonathan Fielden.   

Abstract

Capillary leak syndrome (CLS) commonly occurs in the intensive care setting. CLS is seen in conditions such as septic shock or may result from conditions such as multitrauma and pancreatitis, which result in the systemic inflammatory response syndrome (SIRS). We present two cases in which both patients suffered with CLS, which we believe was caused following administration of granulocyte colony-stimulating factor, to our knowledge not described in the intensive care patient previously. We discuss how these patients management differs from other intensive care unit patients with CLS and how it is important to diagnose this condition early in haematological oncology cases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692521     DOI: 10.1038/sj.thj.6200211

Source DB:  PubMed          Journal:  Hematol J        ISSN: 1466-4860


  7 in total

1.  A case report of idiopathic systemic capillary leak syndrome that occurred during the postoperative period of abdominoperineal resection for colorectal cancer.

Authors:  Tsuyoshi Ozawa; Hironori Yamaguchi; Tomomichi Kiyomatsu; Shinsuke Saito; Soichiro Ishihara; Eiji Sunami; Joji Kitayama; Toshiaki Watanabe
Journal:  Int Surg       Date:  2015-01

2.  Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience.

Authors:  Prashant Kapoor; Patricia T Greipp; Eric W Schaefer; Sumithra J Mandrekar; Arif H Kamal; Natalia C Gonzalez-Paz; Shaji Kumar; Philip R Greipp
Journal:  Mayo Clin Proc       Date:  2010-07-15       Impact factor: 7.616

3.  Interleukin-11-induced capillary leak syndrome in primary hepatic carcinoma patients with thrombocytopenia.

Authors:  Wang Kai-Feng; Pan Hong-Ming; Lou Hai-Zhou; Shen Li-Rong; Zhu Xi-Yan
Journal:  BMC Cancer       Date:  2011-05-27       Impact factor: 4.430

4.  Systemic administration of quality- and quantity-controlled PBMNCs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice.

Authors:  Shinichiro Kuroshima; Kazunori Nakajima; Muneteru Sasaki; Takashi I; Yoshinori Sumita; Takayuki Asahara; Izumi Asahina; Takashi Sawase
Journal:  Stem Cell Res Ther       Date:  2019-07-16       Impact factor: 6.832

5.  Systemic capillary leak syndrome following granulocyte colony-stimulating factor therapy in a T-lymphoblastic leukemia/lymphoma patient: a case report.

Authors:  Ahmed H Al Sharie; Yazan O Al Zu'bi; Sarah Al Sharie; Hawra A Baydoun; Farah H Atawneh; Osama Alshari; Dima Albals
Journal:  Memo       Date:  2022-01-21

6.  Transient thrombocytopenia in a cat following G-CSF treatment.

Authors:  Kyeong-Bo Kim; Ju-Hyun An; Jeong-Hwa Lee; Su-Min Park; Hyung Kyu Chae; Woo-Jin Song; Hwa-Young Youn
Journal:  Vet Med Sci       Date:  2021-12-29

7.  Systemic Capillary Leak Syndrome as an Initial Presentation of ALK-Negative Anaplastic Large Cell Lymphoma.

Authors:  Laura S Lourdes; Samer Z Al-Quran; Nam H Dang; Merry-Jennifer Markham
Journal:  Case Rep Hematol       Date:  2012-03-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.